Cargando…
Corrigendum to “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management” [Thromb. Res., 194, October 2020, Pages 101–115]
Autores principales: | Abou-Ismail, Mouhamed Yazan, Diamond, Akiva, Kapoor, Sargam, Arafah, Yasmin, Nayak, Lalitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691845/ https://www.ncbi.nlm.nih.gov/pubmed/33250201 http://dx.doi.org/10.1016/j.thromres.2020.11.012 |
Ejemplares similares
-
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020) -
Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022) -
Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020) -
Erratum: The Open Dentistry Journal, 2010, volume (4): page. 191-194, 191-194 Bruno O [corrected to Orlando B]
Publicado: (2012) -
Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study. Brandon Metra, Ross Summer, Sandra Elaine Brooks, et al. Thromb Res. 2021;205:84-91.
Publicado: (2022)